Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025)

Agios Pharmaceuticals (AGIO) reported Change in Taxes of -$683000.0 for Q2 2025, down 263.3% quarter-over-quarter from -$188000.0 in Q1 2025.

Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025) Analysis & Trends

Agios Pharmaceuticals has reported Change in Taxes for 6 years, with the latest figure at -$683000.0 in Q2 2025.

For the quarter ending Q2 2025, Change in Taxes changed N/A year-over-year to -$683000.0; the trailing twelve-month figure through Mar 2026 stood at -$683000.0 (down 200.0% YoY), and the FY2025 full-year result was -$871000.0, down 200.0% from the prior year.
Change in Taxes for Q2 2025 stood at -$683000.0, down from -$188000.0 in the prior quarter.
The five-year high for Change in Taxes was $52.7 million in Q3 2024, with the low at -$51.8 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Agios Pharmaceuticals	2.01 Bn	2.01 Bn	19.43 Mn	-

Download Data